Literature DB >> 11147757

Evaluation of the Finnish versions of the functional indices BASFI and DFI in spondylarthropathy.

S Heikkilä1, J V Viitanen, H Kautianen, M Kauppi.   

Abstract

The aim of the study was to compare and evaluate the usefulness of Finnish versions of two functional indices used in spondylarthropathies. Seventy consecutive inpatients with different kinds of spondylarthropathies filled in self-administered questionnaires: the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index for spondylarthropathies (DFI). Cronbach's alpha as a coefficient of internal consistency was analysed for BASFI and DFI. Test-retest reliability was evaluated in 30 patients. For validity the functional indices were compared with the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), erythrocyte sedimentation rate (ESR), spinal movement measures of chest expansion (CE), Schober S1 test and occiput-to-wall distance (OWD), and radiological changes in the lumbar spine (RTGLS) and sacroiliac joints (RTGSI). The reproducibility of the indices BASFI and DFI was good; the intraclass correlation coefficient (ICC) for reliability was 0.99 and 0.98, and the coefficient of internal consistency (Cronbach's alpha) was 0.94 for both BASFI and DFI. The functional indices correlated well with each other, r = 0.85 (95% CI 0.78-0.90). Validity in terms of correlation coefficients between disease activity index BASDAI and functional indices BASFI and DFI was 0.74 (95% CI 0.60-0.84) and 0.69 (95% CI 0.53-0.80), respectively. BASFI and DFI correlated with spinal mobility measurements and RTGLS, but DFI did not correlate with RTGSI. Neither BASFI nor DFI correlated with ESR and disease duration, and only DFI correlated with age. In conclusion, BASFI and DFI are reliable and valid for Finnish inpatients with spondylarthropathies. It is important to know that cultural differences do not reduce the usefulness of these indices.

Entities:  

Mesh:

Year:  2000        PMID: 11147757     DOI: 10.1007/pl00011179

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

1.  Translation and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional Index (BASFI) for use in Ukraine.

Authors:  Oleg Nadashkevich; Oleksiy Masyk
Journal:  Clin Rheumatol       Date:  2011-04-15       Impact factor: 2.980

2.  Evaluation of the incidence of haemorrhoidal disease in patients with ankylosing spondylitis.

Authors:  Mehmet Caglayan; Ahmet Türkoğlu; Pelin Oktayoglu; Mehmet Yıldız; Abdullah Zübeyir Dağlı; Abdullah Böyük; Serda Em; Mehtap Bozkurt; Kemal Nas
Journal:  Clin Rheumatol       Date:  2014-07-02       Impact factor: 2.980

3.  Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis.

Authors:  Samira Rostom; Karima Benbouaaza; Bouchra Amine; Rachid Bahiri; Yousra Ibn Yacoub; Sanae Ali Ou Alla; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2010-04-10       Impact factor: 2.980

4.  Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis.

Authors:  Katayoon Bidad; Sasan Fallahi; Mahdi Mahmoudi; Ahmadreza Jamshidi; Elham Farhadi; Alipasha Meysamie; Mohammad Hossein Nicknam
Journal:  Rheumatol Int       Date:  2011-11-20       Impact factor: 2.631

5.  Evaluation of the Turkish version of the Dougados functional index in ankylosing spondylitis.

Authors:  Huseyin T E Ozer; Tunay Sarpel; Bozkurt Gulek; Z Nazan Alparslan; Eren Erken
Journal:  Rheumatol Int       Date:  2005-03-02       Impact factor: 2.631

6.  Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative?

Authors:  Siddharth Bethi; Abhijit Dasgupta; Michael H Weisman; Thomas J Learch; Lianne S Gensler; John C Davis; John D Reveille; Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

7.  The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity.

Authors:  Altinay Goksel Karatepe; Yesim Akkoc; Servet Akar; Yesim Kirazli; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-07-10       Impact factor: 2.631

8.  Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan.

Authors:  James Cheng-Chung Wei; Ruey-Hong Wong; Jun-Huang Huang; Chen-Tung Yu; Chung-Tei Chou; Ming-Shiou Jan; Gregory J Tsay; Ming-Chih Chou; Hong-Shen Lee
Journal:  Clin Rheumatol       Date:  2007-02-08       Impact factor: 2.980

9.  The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity.

Authors:  Huseyin T E Ozer; Tunay Sarpel; Bozkurt Gulek; Z Nazan Alparslan; Eren Erken
Journal:  Clin Rheumatol       Date:  2004-08-31       Impact factor: 2.980

10.  Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS.

Authors:  Burcu Yanik; Yeşim Kurtaiş Gürsel; Sehim Kutlay; Saime Ay; Atilla Halil Elhan
Journal:  Clin Rheumatol       Date:  2004-09-08       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.